Irritable bowel syndrome: recent and novel therapeutic approaches.
about
Oral probiotics for infantile colicNovel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensationEfficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndromeAn Endogenous Tachykinergic NK2/NK3 Receptor Cascade System Controlling the Release of Serotonin from Colonic MucosaFunctional GI disorders: from animal models to drug development.The serotonin transporter polymorphism rs25531 is associated with irritable bowel syndromePostinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis.Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.Tales from the crypts: regulatory peptides and cytokines in gastrointestinal homeostasis and diseasePrevalence of restless legs syndrome in patients with irritable bowel syndrome.Comparison of the Effects of pH-Dependent Peppermint Oil and Synbiotic Lactol (Bacillus coagulans + Fructooligosaccharides) on Childhood Functional Abdominal Pain: A Randomized Placebo-Controlled StudySerotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptorChanges in salivary physiological stress markers induced by muscle stretching in patients with irritable bowel syndrome.How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trialDo corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies.Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs.Irritable bowel syndrome: focus on otilonium bromide.5-HT7 receptor signaling: improved therapeutic strategy in gut disordersEffect of electro-acupuncture on substance P, its receptor and corticotropin-releasing hormone in rats with irritable bowel syndrome.Effect of electro-acupuncture at different acupoints on neuropeptide and somatostatin in rat brain with irritable bowel syndrome.The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice.
P2860
Q24199006-98F12B6B-987B-4EEE-B99A-1511B6AC7E34Q24644669-DA092238-99B6-4E82-97DD-FA8C7BFE7DDBQ24684839-C5C353BC-1EC2-4D71-8719-88393F1BED1EQ28081884-0DE7DC14-5CFE-4E29-91E3-CC91F9342E61Q30433078-45BBA4BA-FA30-4F03-8086-99AA626AFF67Q34118117-5A4DD5FC-C23D-46A3-9E20-E4EC950E7D11Q34660809-76AE3670-5E7C-4A61-9378-4030913D869CQ34765145-5C483EF9-F267-4F4D-9A8B-E8CAB7BE0BDAQ35251062-B00049EF-548C-4F97-8F3F-769687E6F001Q35555727-42AA6788-606B-4510-8ABA-AAF6AB4B3C72Q35645045-F20A908C-AF64-4D1B-B2D5-C705D63E9367Q35751021-ED381E73-F334-4DAB-B5A3-B3495E2CC7DAQ36987064-7E0A4BED-A93F-423E-809B-6CD08E74D0DDQ37105074-4693B54C-85CC-46CA-B412-CBCC9D2E47D3Q37231289-2B169358-4C7C-4AA6-BD8E-1ABB82B4B63BQ37880195-B6EA031D-DE7D-4822-8E04-6F2EC69A58C0Q38086870-D466FC89-E02F-49B0-BEFC-712D54C736DCQ38177848-2D89F3B4-471D-43A5-B9C1-6CBBC9CD61CDQ38310117-62189072-DA3E-41AE-9C42-6B07919EE980Q41992781-DAA5C1D0-A7E2-4E16-8FB6-8BA0C9CF6190Q48174570-36BED6CD-593C-4538-B026-1C5C440EFB30Q50975152-748F1AC3-21CD-4D3D-9578-D33EF67A6601
P2860
Irritable bowel syndrome: recent and novel therapeutic approaches.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Irritable bowel syndrome: recent and novel therapeutic approaches.
@ast
Irritable bowel syndrome: recent and novel therapeutic approaches.
@en
type
label
Irritable bowel syndrome: recent and novel therapeutic approaches.
@ast
Irritable bowel syndrome: recent and novel therapeutic approaches.
@en
prefLabel
Irritable bowel syndrome: recent and novel therapeutic approaches.
@ast
Irritable bowel syndrome: recent and novel therapeutic approaches.
@en
P1433
P1476
Irritable bowel syndrome: recent and novel therapeutic approaches.
@en
P2093
Viola Andresen
P304
P356
10.2165/00003495-200666080-00004
P577
2006-01-01T00:00:00Z
P6179
1026576823